Andy Nong

2.5k total citations
60 papers, 1.7k citations indexed

About

Andy Nong is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Nutrition and Dietetics. According to data from OpenAlex, Andy Nong has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Health, Toxicology and Mutagenesis, 22 papers in Cancer Research and 12 papers in Nutrition and Dietetics. Recurrent topics in Andy Nong's work include Carcinogens and Genotoxicity Assessment (22 papers), Heavy Metal Exposure and Toxicity (18 papers) and Effects and risks of endocrine disrupting chemicals (17 papers). Andy Nong is often cited by papers focused on Carcinogens and Genotoxicity Assessment (22 papers), Heavy Metal Exposure and Toxicity (18 papers) and Effects and risks of endocrine disrupting chemicals (17 papers). Andy Nong collaborates with scholars based in Canada, United States and Tunisia. Andy Nong's co-authors include Sean M. Hays, Lesa L. Aylward, Melvin E. Andersen, Harvey J. Clewell, Kannan Krishnan, David C. Dorman, Michael D. Taylor, Michelle Gagné, Russell S. Thomas and Miyoung Yoon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemosphere and Environment International.

In The Last Decade

Andy Nong

59 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Nong Canada 24 1.1k 336 268 252 223 60 1.7k
Moiz Mumtaz United States 28 1.3k 1.1× 442 1.3× 138 0.5× 321 1.3× 279 1.3× 92 2.2k
G. P. Daston United States 15 1.1k 1.0× 246 0.7× 185 0.7× 290 1.2× 230 1.0× 30 1.8k
Hana R. Pohl United States 22 1.2k 1.1× 318 0.9× 125 0.5× 314 1.2× 124 0.6× 70 1.8k
Miyoung Yoon United States 20 797 0.7× 186 0.6× 142 0.5× 135 0.5× 128 0.6× 69 1.5k
P. Robinan Gentry United States 26 1.0k 0.9× 577 1.7× 83 0.3× 153 0.6× 211 0.9× 65 1.8k
Andrew Maier United States 21 775 0.7× 374 1.1× 69 0.3× 123 0.5× 274 1.2× 80 1.6k
Lynne T. Haber United States 21 594 0.5× 345 1.0× 180 0.7× 191 0.8× 392 1.8× 58 1.7k
Rogelio Tornero‐Velez United States 26 1.1k 1.0× 278 0.8× 61 0.2× 286 1.1× 178 0.8× 61 1.9k
Christopher R. Kirman United States 26 984 0.9× 445 1.3× 56 0.2× 140 0.6× 176 0.8× 84 1.8k
Bette Meek Canada 12 480 0.4× 181 0.5× 132 0.5× 136 0.5× 174 0.8× 18 1.2k

Countries citing papers authored by Andy Nong

Since Specialization
Citations

This map shows the geographic impact of Andy Nong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Nong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Nong more than expected).

Fields of papers citing papers by Andy Nong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Nong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Nong. The network helps show where Andy Nong may publish in the future.

Co-authorship network of co-authors of Andy Nong

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Nong. A scholar is included among the top collaborators of Andy Nong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Nong. Andy Nong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wambaugh, John F., Katie Paul Friedman, Marc A. Beal, et al.. (2025). Applying New Approach Methods for Toxicokinetics for Chemical Risk Assessment. Chemical Research in Toxicology. 38(8). 1408–1441.
4.
Andersen, Melvin E., Andy Nong, Nataliya A. Karyakina, et al.. (2020). Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring data. Regulatory Toxicology and Pharmacology. 114. 104671–104671. 9 indexed citations
5.
Gannon, Anne Marie, Marjory Moreau, Reza Farmahin, et al.. (2019). Hexabromocyclododecane (HBCD): A case study applying tiered testing for human health risk assessment. Food and Chemical Toxicology. 131. 110581–110581. 20 indexed citations
6.
Gouliarmou, Varvara, Alfonso M. Lostia, Sandra Coecke, et al.. (2018). Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance. Toxicology in Vitro. 53. 233–244. 24 indexed citations
7.
Aylward, Lesa L., et al.. (2016). Biomonitoring Equivalents for interpretation of silver biomonitoring data in a risk assessment context. International Journal of Hygiene and Environmental Health. 219(6). 521–526. 10 indexed citations
8.
Farmahin, Reza, Andrew Williams, Byron Kuo, et al.. (2016). Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment. Archives of Toxicology. 91(5). 2045–2065. 135 indexed citations
11.
Hays, Sean M., Kristin Macey, Andy Nong, & Lesa L. Aylward. (2014). Biomonitoring Equivalents for selenium. Regulatory Toxicology and Pharmacology. 70(1). 333–339. 68 indexed citations
12.
Kirman, Christopher R., Lesa L. Aylward, Sean M. Hays, Kannan Krishnan, & Andy Nong. (2011). Biomonitoring Equivalents for DDT/DDE. Regulatory Toxicology and Pharmacology. 60(2). 172–180. 49 indexed citations
13.
Aylward, Lesa L., Kannan Krishnan, Christopher R. Kirman, Andy Nong, & Sean M. Hays. (2011). Biomonitoring Equivalents for deltamethrin. Regulatory Toxicology and Pharmacology. 60(2). 189–199. 34 indexed citations
14.
Schroeter, Jeffry D., Andy Nong, Miyoung Yoon, et al.. (2010). Analysis of Manganese Tracer Kinetics and Target Tissue Dosimetry in Monkeys and Humans with Multi-Route Physiologically Based Pharmacokinetic Models. Toxicological Sciences. 120(2). 481–498. 52 indexed citations
15.
Andersen, Melvin E., David C. Dorman, Harvey J. Clewell, Michael D. Taylor, & Andy Nong. (2010). Multi-Dose-Route, Multi-Species Pharmacokinetic Models for Manganese and Their Use in Risk Assessment. Journal of Toxicology and Environmental Health. 73(2-3). 217–234. 24 indexed citations
16.
Aylward, Lesa L., Sean M. Hays, Michelle Gagné, Andy Nong, & Kannan Krishnan. (2010). Biomonitoring equivalents for hexachlorobenzene. Regulatory Toxicology and Pharmacology. 58(1). 25–32. 23 indexed citations
17.
Yoon, Miyoung, Andy Nong, Harvey J. Clewell, et al.. (2009). Evaluating Placental Transfer and Tissue Concentrations of Manganese in the Pregnant Rat and Fetuses after Inhalation Exposures with a PBPK Model. Toxicological Sciences. 112(1). 44–58. 66 indexed citations
18.
Nong, Andy, Michael D. Taylor, Harvey J. Clewell, David C. Dorman, & Melvin E. Andersen. (2008). Manganese Tissue Dosimetry in Rats and Monkeys: Accounting for Dietary and Inhaled Mn with Physiologically based Pharmacokinetic Modeling. Toxicological Sciences. 108(1). 22–34. 37 indexed citations
19.
Nong, Andy & Kannan Krishnan. (2007). Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach. Regulatory Toxicology and Pharmacology. 48(1). 93–101. 11 indexed citations
20.
Nong, Andy, D. Gail McCarver, Ronald N. Hines, & Kannan Krishnan. (2006). Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: A case study with toluene. Toxicology and Applied Pharmacology. 214(1). 78–87. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026